Keywords
freshwater ecosystems
environmental policy
One Health approach
sustainable water management
How to Cite
Abstract
Purpose: This article examines the ecological risks posed by pharmaceutical pollutants in freshwater resources and evaluates policy responses for mitigating their environmental impact. Methodology/Approach: The study synthesises recent empirical findings and regulatory reports, with emphasis on European freshwater monitoring data and ecotoxicological assessments. Findings: Pharmaceuticals such as antibiotics, NSAIDs, and hormones are consistently detected in surface waters at nanogram- to microgram-level concentrations, contributing to microbial community shifts, reproductive disruption in aquatic species, and the development of antimicrobial resistance. Existing regulatory frameworks address only a limited subset of compounds, resulting in persistent contamination even in regions with advanced wastewater treatment. Research Limitations/Implications: Data gaps remain regarding long-term synergistic effects and low-dose chronic exposure. Practical/Social Implications: Improved wastewater management and One Health-oriented governance could reduce ecological and public health risks. Originality/Value: The article highlights systemic regulatory shortcomings and identifies priority areas for sustainable freshwater policy reform.
References
Ashiwaju, B. I., Uzougbo, C. G., & Orikpete, O. F. (2023). Environmental impact of pharmaceuticals: A comprehensive review. Matrix Science Pharma, 7(3), 85-94. https://doi.org/10.4103/mtsp.mtsp_15_23
aus der Beek, T., Römer, I., Dietrich, C., & Ternes, T. A. (2018). Pharmaceuticals in surface waters: Monitoring results from 20 European countries. Science of the Total Environment, 615, 818–833. https://doi.org/10.1016/j.scitotenv.2017.09.013
aus der Beek, T., Weber, F. A., Bergmann, A., Hickmann, S., Ebert, I., Hein, A., & Küster, A. (2016). Pharmaceuticals in the environment—Global occurrences and perspectives. Environmental Toxicology and Chemistry, 35(4), 823–835. https://doi.org/10.1002/etc.3339
Brooke, B., Brain, K., & Boxall, A. (2009). Pharmaceuticals in the environment: Predicting ecological risk. Environmental Toxicology and Chemistry, 28(12), 2471–2477.
Caban, M., & Stepnowski, P. (2021). Pharmaceutical residues in aquatic environments: Occurrence and removal methods. Journal of Environmental Management, 292, 112–119. https://doi.org/10.1016/j.jenvman.2021.112119
Clara, M., Strenn, B., & Kreuzinger, N. (2004). Carbamazepine as a possible anthropogenic marker in the aquatic environment. Water Research, 38(4), 947–954. https://doi.org/10.1016/j.watres.2003.10.058
Daughton, C. G., & Ternes, T. A. (1999). Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environmental Health Perspectives, 107(Suppl. 6), 907–938. https://doi.org/10.1289/ehp.99107s6907
European Environment Agency (EEA). (2020). European waters: Status and pressures 2020. Copenhagen: European Environment Agency.
European Environment Agency (EEA). (2022). European waters: Assessment of status and pressures 2022. Copenhagen: European Environment Agency.
Hai, F. I., Yamamoto, K., & Fukushi, H. (2018). Removal of pharmaceuticals from wastewater by advanced treatment processes. Journal of Environmental Management, 230, 80–92. https://doi.org/10.1016/j.jenvman.2018.09.001
Johnson, A. C., & Sumpter, J. P. (2015). Do concentrations of pharmaceuticals in European rivers exceed environmental thresholds? Science of the Total Environment, 511, 747–755. https://doi.org/10.1016/j.scitotenv.2014.12.055
Kostich, M. S., Batt, A. L., & Lazorchak, J. M. (2014). Predicting variability of pharmaceuticals in surface waters. Environmental Toxicology and Chemistry, 33(2), 342–349. https://doi.org/10.1002/etc.2459
Kümmerer, K. (2010). Pharmaceuticals in the environment. Annual Review of Environment and Resources, 35, 57–75. https://doi.org/10.1146/annurev-environ-052809-161223
Larsson, D. G. J. (2014). Pollution from drug manufacturing: Review and perspectives. Philosophical Transactions of the Royal Society B, 369, 20130571. https://doi.org/10.1098/rstb.2013.0571
Larsson, D. G. J., de Pedro, C., & Paxeus, N. (2007). Effluent from drug manufactures contains extremely high levels of pharmaceuticals. Journal of Hazardous Materials, 148(3), 751–755. https://doi.org/10.1016/j.jhazmat.2007.07.008
Mohapatra, P. K., Brar, S. K., & Tyagi, R. D. (2014). Occurrence and treatment of pharmaceuticals in wastewater. Science of the Total Environment, 408, 97–110. https://doi.org/10.1016/j.scitotenv.2009.09.043
Moldovan, V., Popescu, A., & Ionescu, I. (2023). Occurrence of pharmaceutical residues in European river systems and implications for environmental quality standards. Environmental Pollution, 326, 121–134. https://doi.org/10.1016/j.envpol.2023.121134
Rayan, M., El-Sayed, A., & Abdel-Rahman, H. (2023). Environmental occurrence of antibiotics and antimicrobial resistance in aquatic systems. Environmental Pollution, 316, 120–135. https://doi.org/10.1016/j.envpol.2022.120135
Umweltbundesamt (UBA). (2022). Pharmaceuticals in the aquatic environment – Occurrence and environmental risk assessment. Dessau-Roßlau: German Environment Agency.
Verlicchi, M., Galletti, A., & Masotti, G. (2015). Pharmaceuticals in wastewater: Environmental occurrence and ecological risks. Science of the Total Environment, 514, 467–491. https://doi.org/10.1016/j.scitotenv.2015.02.020
Verlicchi, M., & Grillini, E. (2020). Surface water and groundwater contamination by pharmaceuticals and personal care products. Environmental Science and Pollution Research, 27, 10202–10235. https://doi.org/10.1007/s11356-020-08067-0
Water Europe. (2021). Pharmaceutical pollutants and water quality management in Europe. Brussels: Water Europe.
Water News Europe. (2021). Only 30% of EU surface waters achieve good chemical status under the Water Framework Directive.
PubMed. (2019). Pharmaceutical residues in freshwater ecosystems: occurrence, monitoring and ecological risks. Bethesda: National Library of Medicine.
Umweltbundesamt (2022). Pharmaceuticals in the aquatic environment – occurrence, monitoring and environmental risk assessment. Dessau-Roßlau: UBA.
Water Europe. (2021). Pharmaceutical pollutants and water quality management in Europe. Brussels: Water Europe.
European Environment Agency (2020). European waters: Status and pressures 2020. Copenhagen: European Environment Agency.
Vasile Moldovan, Ana Popescu, & Ion Ionescu (2023). Occurrence of pharmaceutical residues in European river systems and implications for environmental quality standards. Environmental Pollution, 326, 121–134.
Ortúzar, M., Esterhuizen, M., Olicon-Hernandez, D., Gonzales-Lopez, J., & Aranda, E. (2022). Pharmaceutical pollution in aquatic environments: Current status and bioremediation perspectives. Frontiers in Microbiology, 13, 869332. https://doi.org/10.3389/fmicb.2022.869332
Parker, G., & Miller, F. A. (2024). Tackling pharmaceutical pollution along the product lifecycle. Pharmacy, 12(6), 173. https://doi.org/10.12968/hmed.2024.0841
Patel, M., Kumar, R., Kishor, K., Mlsna, T., Pittman, C. U., & Mohan, D. (2019). Pharmaceuticals of emerging concern in aquatic systems: Chemistry, occurrence, effects, and removal methods. Chemical Reviews, 119(6), 3510–3673. https://doi.org/10.1021/acs.chemrev.8b00299
Rodrigues, F., Durães, L., Simones, N. E. C., Pereira, A. M. P. T., Silva, L. J. G., & Feio, M. J. (2025). Pharmaceuticals in urban streams: A review of their detection and effects in the ecosystem. Water Research, 268(Part B), 122657. https://doi.org/10.1016/j.watres.2024.122657
Umweltbundesamt (UBA). (2022). Pharmaceuticals in the environment: Occurrence, effects, and options for action. German Environment Agency Report. https://doi.org/10.13140/RG.2.2.23450.13769
Wada, O. Z., & Olawade, D. B. (2025). Recent occurrence of pharmaceuticals in freshwater, emerging treatment technologies, and future considerations: A review. Chemosphere, 374, 144153. https://doi.org/10.1016/j.chemosphere.2025.144153
Wang, X., Li, Q., & Zhao, Y. (2025). Evaluation of micropollutant removal efficiencies in conventional and advanced wastewater treatment processes. Drinking Water Engineering and Science, 18, 101356. https://doi.org/10.1016/j.dwt.2025.101356
Welch, S. A., Olsen, K., Nouri Sharikabad, M., Tollefsen, K. E., Grung, M., & Moe, S. J. (2022). Pharmaceutical pollution: Prediction of environmental concentrations from national wholesales data. Open Research Europe, 2, 71. https://doi.org/10.12688/openreseurope.14102.2
Wilkinson, J. L., Boxall, A. B. A., Kolpin, D. W., Leung, K. M. Y., Lai, R. W. S., Galbán-Malagón, C., … & Teta, C. (2022). Pharmaceutical pollution of the world’s rivers. PNAS, 119(8), e2113947119. https://doi.org/10.1073/pnas.2113947119
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) 2026 Economics and Environment